UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.37 -0.01 (-0.01%) GOLD FUTURES
2,322.50 -1.70 (-0.07%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,421.70 -371.24 (-0.73%)
Hikma Pharmaceuticals PLC (H5P.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:49PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 5.07B |
| Enterprise value | 5.96B |
| Trailing P/E | 28.86 |
| Forward P/E | 12.25 |
| PEG ratio (5-yr expected) | 2.33 |
| Price/sales (ttm) | 1.90 |
| Price/book (mrq) | 2.48 |
| Enterprise value/revenue | 2.07 |
| Enterprise value/EBITDA | 10.80 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.44 |
| 52-week change 3 | 6.54% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 25.60 |
| 52-week low 3 | 19.70 |
| 50-day moving average 3 | 22.06 |
| 200-day moving average 3 | 22.49 |
Share statistics
| Avg vol (3-month) 3 | 1 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 221.88M |
| Implied shares outstanding 6 | 222.35M |
| Float 8 | 154.66M |
| % held by insiders 1 | 30.65% |
| % held by institutions 1 | 38.77% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.67 |
| Forward annual dividend yield 4 | 2.94% |
| Trailing annual dividend rate 3 | 0.72 |
| Trailing annual dividend yield 3 | 3.16% |
| 5-year average dividend yield 4 | 2.03 |
| Payout ratio 4 | 72.75% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 21 Mar 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 6.61% |
| Operating margin (ttm) | 21.41% |
Management effectiveness
| Return on assets (ttm) | 8.46% |
| Return on equity (ttm) | 8.81% |
Income statement
| Revenue (ttm) | 2.88B |
| Revenue per share (ttm) | 13.02 |
| Quarterly revenue growth (yoy) | 11.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 791M |
| Net income avi to common (ttm) | 190M |
| Diluted EPS (ttm) | 0.79 |
| Quarterly earnings growth (yoy) | 293.30% |
Balance sheet
| Total cash (mrq) | 229M |
| Total cash per share (mrq) | 1.04 |
| Total debt (mrq) | 1.19B |
| Total debt/equity (mrq) | 53.92% |
| Current ratio (mrq) | 1.57 |
| Book value per share (mrq) | 9.94 |
Cash flow statement
| Operating cash flow (ttm) | 608M |
| Levered free cash flow (ttm) | 445.25M |
© 2024 Yahoo. All rights reserved.